Drugs / Intrathecal Triples
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 2 | NCT02518750 Background | Nov 2016 → Mar 2018 | T-cell leukemia, acute lymphoblastic leukemia | St. Jude Children's Research Hospital | Terminated | No outcome recorded Stop: Enrollment |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Intrathecal Triples | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02518750 ↗ |
| Route | Intrathecal | “intrathecal methotrexate/hydrocortisone/cytarabine” NCT02518750 ↗ |